New I3LUNG project to fund AI tools for improving treatment and outcomes for lung cancer patients
The University of Chicago Medicine has joined the I3LUNG project, a research initiative funded by a five-year, €10M grant from the European Union to develop a decision-making tool for creating individually tailored lung cancer treatment plans. The project will use artificial intelligence (AI) software and machine learning to analyze a wide range of information from clinical data, radiology images, and biological characteristics of tumors. “This highly innovative project has the goal of using machine learning and artificial intelligence to predict the outcomes of immunotherapy, which is something we are not currently capable of doing,” said Marina Garassino, MD, Professor of Medicine and the leader of … Read More